Home/Filings/4/0001610717-23-000427
4//SEC Filing

Hindson Benjamin J. 4

Accession 0001610717-23-000427

CIK 0001770787other

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 4:19 PM ET

Size

6.7 KB

Accession

0001610717-23-000427

Insider Transaction Report

Form 4
Period: 2023-12-28
Hindson Benjamin J.
DirectorSee Remarks
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-12-288,33414,978 total
    Exercise: $11.48Exp: 2029-05-10Class A Common Stock (8,334 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2023-12-28$11.48/sh+8,334$95,674285,672 total
Footnotes (1)
  • [F1]All of the shares subject to the option are fully vested and exercisable as of the date hereof.

Documents

1 file

Issuer

10x Genomics, Inc.

CIK 0001770787

Entity typeother

Related Parties

1
  • filerCIK 0001786391

Filing Metadata

Form type
4
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:19 PM ET
Size
6.7 KB